Home > Financial Ratios > INDO US BIOTECH

INDO US BIOTECH
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 15.2113.8513.759.979.64

What is the latest Core EBITDA Margin ratio of INDO US BIOTECH ?

The latest Core EBITDA Margin ratio of INDO US BIOTECH is 15.21 based on Mar2023 Standalone results.
Year Core EBITDA Margin
Mar202315.21
Mar202213.85
Mar202113.75
Mar20209.97
Mar20199.64

How is Core EBITDA Margin of INDO US BIOTECH Trending?

Years Core EBITDA Margin % Change
Mar2023 15.21
9.82
Mar2022 13.85
0.73
Mar2021 13.75
37.91
Mar2020 9.97
3.42
Mar2019 9.64 -

Other Financial Ratios of INDO US BIOTECH


Compare Core EBITDA Margin ratio of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹422.1 Cr 5% -12.5% 180.3% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,840.8 Cr 1.1% 2.4% 61.3% Stock Analytics
KAVERI SEED COMPANY ₹4,371.0 Cr -0.3% 23.7% 66.4% Stock Analytics
VENKYS (INDIA) ₹2,537.5 Cr 0.6% 1.4% 11.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹2,235.2 Cr 0.7% -3.9% -38.2% Stock Analytics
TIERRA AGROTECH ₹348.8 Cr -18.5% -25.3% -54.6% Stock Analytics


INDO US BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

5%

-12.5%

180.3%

SENSEX

1.7%

1.5%

18.7%


You may also like the below Video Courses